Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -66.02% is 60% below its 5-year average of -41.38%, near the low end of its 5-year range (-81.44%–-24.48%).
107.58% below its 12-month average of -31.80%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -10.13%.
RETURN ON ASSETS (ROA)
-66.02%
RETURN ON ASSETS (ROA) AVG TTM
-31.80%
RETURN ON ASSETS (ROA) AVG 3Y
-35.60%
RETURN ON ASSETS (ROA) AVG 5Y
-41.38%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-107.58%
CURRENT VS 3Y AVG
-85.46%
CURRENT VS 5Y AVG
-59.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
-115.05%
vs the sector median at left
Erasca, Inc.
Market Cap
$5.05B
Return on Assets (ROA)
-66.02%
TTM Avg
-31.80%
3Y Avg
-35.60%
5Y Avg
-41.38%
Market Cap
$5.09B
Return on Assets (ROA)
5.08%
TTM Avg
4.88%
3Y Avg
4.58%
5Y Avg
3.44%
Market Cap
$5.14B
Return on Assets (ROA)
-78.04%
TTM Avg
-72.67%
3Y Avg
-59.05%
5Y Avg
-50.29%
Market Cap
$5.20B
Return on Assets (ROA)
-17.02%
TTM Avg
-21.01%
3Y Avg
-19.47%
5Y Avg
-13.88%
Market Cap
$5.22B
Return on Assets (ROA)
-45.20%
TTM Avg
-56.55%
3Y Avg
-55.28%
5Y Avg
-47.01%
Market Cap
$4.86B
Return on Assets (ROA)
-82.32%
TTM Avg
-7.94%
3Y Avg
-19.90%
5Y Avg
-25.16%
Market Cap
$4.84B
Return on Assets (ROA)
-11.66%
TTM Avg
-21.36%
3Y Avg
-19.96%
5Y Avg
-22.39%
Market Cap
$5.27B
Return on Assets (ROA)
4.94%
TTM Avg
1.92%
3Y Avg
-0.50%
5Y Avg
0.13%
Market Cap
$4.82B
Return on Assets (ROA)
-2.47%
TTM Avg
-26.65%
3Y Avg
-27.96%
5Y Avg
-27.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $5.05B | -66.02% | -31.80% | -35.60% | -41.38% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.09B | 5.08% | 4.88% | 4.58% | 3.44% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.14B | -78.04% | -72.67% | -59.05% | -50.29% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.20B | -17.02% | -21.01% | -19.47% | -13.88% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.22B | -45.20% | -56.55% | -55.28% | -47.01% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.86B | -82.32% | -7.94% | -19.90% | -25.16% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | -11.66% | -21.36% | -19.96% | -22.39% |
| Sotera Health Company (SHC)vs › | $5.27B | 4.94% | 1.92% | -0.50% | 0.13% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.82B | -2.47% | -26.65% | -27.96% | -27.52% |
| Doximity, Inc. (DOCS)vs › | $5.32B | 15.41% | 17.55% | 14.67% | 15.71% |
ROA
-66.0%
ROE
-79.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -31.44% |
| 2024-12-31 | -32.17% |
| 2023-12-31 | -31.63% |
| 2022-12-31 | -47.15% |
| 2021-12-31 | -24.48% |
| 2020-12-31 | -81.44% |
| 2019-12-31 | -21.69% |
